FORM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FormFactor Inc (FORM) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company's financial performance is solid and hedge funds are showing significant interest, the recent sharp drop in price (-7.14% in regular market trading) and lack of strong proprietary trading signals suggest waiting for a more favorable entry point. Analysts have raised price targets, but the stock's valuation and current price trend do not align with an immediate buy recommendation.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 55.527, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock has seen a sharp decline in the regular market (-7.14%), indicating potential short-term weakness. Key support is at 90.549, and resistance levels are at 106.746 and 111.749.
Hedge funds are buying heavily, with a 310.96% increase in buying activity last quarter.
Strong financial performance in Q4 2025, with revenue up 13.55% YoY, net income up 139.24% YoY, and EPS up 141.67% YoY.
Analysts have raised price targets significantly, with some projecting up to $100, indicating confidence in the company's future growth.
The stock experienced a sharp decline of -7.14% in the regular market, which could signal short-term weakness.
No recent news or event-driven catalysts to drive immediate buying interest.
Insider trading trends are neutral, and no significant congressional trading data is available.
FormFactor reported strong Q4 2025 financials, with revenue increasing to $215.16M (up 13.55% YoY), net income rising to $23.22M (up 139.24% YoY), and EPS improving to $0.29 (up 141.67% YoY). Gross margin also expanded to 42.18%, up 8.63% YoY, indicating strong operational efficiency.
Analysts are generally positive on FormFactor, with multiple firms raising price targets significantly after the Q4 'beat and raise' report. However, many analysts maintain Hold ratings, citing valuation concerns after the stock's recent rise. The highest price target is $100, which aligns with the current price, suggesting limited upside in the near term.
